ArticleJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2021

Tumor-Induced Osteomalacia: Treatment Progress Using Burosumab, an Anti-FGF23 Monoclonal Antibody.

Michael P WhytePubMed ↗Publisher ↗

No numbers read from the abstract.